APOE4 alters the accessible-cholesterol threshold sensed by SCAP through ER membrane composition changes
🧪 Overview
A more conjectural model is that APOE4-driven lipid remodeling changes ER membrane organization so that SCAP perceives cholesterol insufficiency at a given sterol mass. This is conceptually interesting and compatible with accessible-cholesterol biology, but currently lacks direct APOE4-specific evidence and remains below funding priority.
🧬 Mechanism
Curated pathway from expert analysis
flowchart TD
A["APOE4 Isoform<br/>Arg112-Cys158 Structure"]
B["LRP1 Receptor Binding<br/>Hepatic and Neuronal Uptake"]
C["TREM2 Engagement<br/>Microglial State Transition"]
D["DAM Identity<br/>Disease-Associated Microglia"]
E["Lipid Metabolism<br/>Cholesterol Efflux Defect"]
F["Amyloid Clearance<br/>Reduced A-beta Uptake"]
G["Tau Hyperphosphorylation<br/>GSK3B/CDK5 Activation"]
H["Neurofibrillary Tangles<br/>Intraneuronal Pathology"]
I["Synaptic Dysfunction<br/>Neuronal Network Disruption"]
J["Cognitive Decline<br/>Progressive Dementia"]
A --> B
B --> C
C --> D
D --> E
E --> F
A --> G
F -.->|"accelerates"| G
G --> H
D --> I
H --> J
I --> J
style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style J fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — SCAP
No curated PDB or AlphaFold mapping for SCAP yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for SCAP from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for SCAP.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
🔮 Predictions
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF human iPSC-derived neurons carrying APOE4/4 are treated with a range of extracellular cholesterol concentrations (0-20 µg/mL for 6 hours), THEN nuclear SREBP2 accumulation will occur at significant | APOE4/4 neurons will show half-maximal SREBP2 nuclear translocation at ≤5 µg/mL cholesterol versus ≥8 µg/mL for APOE3/3 neurons, reflecting a lowered threshold | — no observation — | pending | 0.45 |
| IF APOE4/4 astrocytes are compared to APOE3/3 astrocytes under sterol-replete conditions (serum-free media with 10 µg/mL cholesterol), THEN total ER membrane accessible cholesterol, measured by choles | Reduced accessible ER cholesterol in APOE4/4 astrocytes will trap more SCAP bound to Insig in the ER, preventing SCAP-SREBP trafficking to the Golgi, with Insig | — no observation — | pending | 0.40 |
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |